Related Experiment Video
Updated: Jul 14, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Transfusion trigger in critically ill patients: has the puzzle been completed?
Eric Reiles1, Philippe Van der Linden
1Department of Anesthesiology Centre, Hospitalo-Unversitaire (CHU) Brugmann and Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Place Van Gehuchten, B-1020, Brussels, Belgium.
A restrictive transfusion strategy using a hemoglobin threshold of 7 g/dl reduced red blood cell (RBC) transfusions in critically ill children without impacting outcomes. This supports using less RBCs for better patient management.
Area of Science:
- Critical Care Medicine
- Hematology
- Pediatric Intensive Care
Background:
- Restrictive transfusion strategies are increasingly studied in various patient populations.
- Previous research in adults suggested benefits of restrictive transfusion.
- The impact on critically ill children required further investigation.
Purpose of the Study:
- To evaluate the effectiveness of a restrictive transfusion strategy in stable, critically ill children.
- To determine if a hemoglobin threshold of 7 g/dl impacts transfusion requirements and patient outcomes.
Main Methods:
- A restrictive transfusion strategy was implemented, targeting a hemoglobin threshold of 7 g/dl.
- Transfusion requirements were monitored.
- Patient outcomes were assessed to evaluate the strategy's impact.
Main Results:
- The restrictive strategy significantly decreased red blood cell (RBC) transfusion requirements.
- No significant difference in patient outcomes was observed between strategies.
- Findings align with previous adult studies and suggest leukoreduction benefits.
Conclusions:
- A restrictive transfusion strategy (hemoglobin threshold of 7 g/dl) is safe and effective in reducing RBC transfusions in critically ill children.
- Higher hemoglobin concentrations via transfusion do not necessarily improve tissue oxygen delivery or clinical outcomes.
- Further research comparing symptomatic vs. hemoglobin-based strategies in high-risk patients is warranted.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...